Background Estimates of the severity of the SARS-CoV-2 omicron variant (B.1.1.529) are
crucial to assess the public health impact associated with its rapid global dissemination. We …

1 Abstract The Omicron SARS-CoV-2 variant of concern (VOC lineage B.1.1.529), which
became dominant in many countries during early 2022, includes several subvariants with …

SARS coronavirus 2 (SARS-CoV-2) continues to evolve and new variants emerge. Using
nationwide Danish data, we estimate the transmission dynamics of SARS-CoV-2 Omicron …

In late 2021, the Omicron SARS-CoV-2 variant overtook the previously dominant Delta variant,
but the extent to which this transition was driven by immune evasion or a change in the …

1 Abstract The Omicron variant of concern (VOC) is a rapidly spreading variant of SARS-CoV-2
that is likely to overtake the previously dominant Delta VOC in many countries by the end …

Background The pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has tremendous consequences for our societies. Knowledge of the seroprevalence …

Background Animals can act as a reservoir and source for the emergence of novel meticillin-resistant
Staphylococcus aureus (MRSA) clones in human beings. Here, we report the …

Background The more infectious SARS-CoV-2 lineage B.1.1.7 rapidly spread in Europe after
December, 2020, and a concern that B.1.1.7 could cause more severe disease has been …

New lineages of SARS-CoV-2 are of potential concern due to higher transmissibility, risk of
severe outcomes, and/or escape from neutralizing antibodies. Lineage B.1.1.7 (the Alpha …

The discovery of antibiotics more than 80 years ago has led to considerable improvements
in human and animal health. Although antibiotic resistance in environmental bacteria is …